09/21/2021 Olympus Water US Holding Corp (Solenis/Innovative Water Care Global Corp/Sigura Water) (SOLEIN) US$2.11bn (down from US$2.4bn) equivalent (US$/EUR) 144A/Reg S 4-part. Via BofA/GS jt lead books/Barc/BMO/DB/MS/Nomura/HSBC/ING/Jefferies/Macquarie/RBC jt books. No reg rights. SMR at 100% of the initial price if the acquisition does not close by 07/03/22. Settles 10/01 (T+8).
- approx US$1.4bn equivalent (US$/EUR) total sr sec notes 2-part:
US$815m sr sec 1st lien notes due 10/01/28 (7y). NC3 (T+50bp), then at 102.125, 101.063, 100. Equity claw: 3y 40% at 104.25. Special call: 10% per year the 1st 3 years at 103. B2/B- (stable/stable). 144A CUSIP: 681639AA8. IPT: US$ low 5s. Px talk: 4.50% area. Revised px talk: 4.25%-4.375%. Priced 4.25% at 100.+ 314bp vs 1.125% 08/31/28.
EUR500m (US$586m equivalent) sr sec 1st lien notes due 10/01/28 (7y). NC3 (MWC B+50bp), then at 101.938, 100.969, 100. Equity claw: 3y 40% at 103.875. Special call: 10% per year the 1st 3 years at 103. B2/B- (stable/stable). Reg S ISIN: XS2391352775. IPT: EUR low 4s. Px talk: 4.00% area. Launched: EUR500m at 3.875%. Priced: 3.875% at 100. +441bp vs DBR 0.25% 098/15/28.
- Approx US$710m equivalent (US$/EUR) (down from US$1bn equivalent) sr notes 2-part:
US$400m sr notes due 10/01/29 (8y). NC3 (MWC T+50%), then at 103.125, 101.563, 100. Equity claw: 3y 40% at 106.25. Caa2/CCC+ (stable/stable). 144A CUSIP: 681639AB6. IPT high 6-7. Px talk: 6.50% area. Revised px talk: 6.25%-6.375%. Priced: 6.25% at 100. +508bp vs 1.625% 08/15/29.
EUR265m (US$310m equivalent) sr notes due 10/01/29 (8y). NC3 (MWC B+50bp), then at 102.688, 101.344, 100. Equity claw: 3y 40% at 105.375. Reg S ISIN: . Caa2/CCC+ (stable/stable). Reg S ISIN: XS239135307. IPT: high 5-6. Px talk: 5.50% area. Launched: EUR265m at 5.375%. Priced: 5.375% at 100. +585bp vs DBR 0.00% 08/15/29.
Roadshow 09/07-20 (investor call at 11:30am NYT/4:30pm UKT Thurs, 09/09). Books closed at 10am NYT 09/21. Reconfirms were due by 11:15am NYT 09/21. UOP: along with US$1.69bn equivalent (US$1.110m and EUR815m) (up from US$1.4bn equivalent) term loan B (US$ priced: L+375bp/0.500% floor/99.75 OID; px talk: L+400bp/0.50%/99.00; IPT +400bp/0.50%/99.00; EUR priced: E+400bp/0.0% floor/99.75; px talk E+400-425bp/0%/99.50; IPT of E+400-425bp/0.00%/99.50), to fund the acquisition of Solenis LLC by Platinum Equity Partners from CD&R (51% along with management) and BASF (49%) for an enterprise value of $5.3bn. Platinum will contribute about $2bn in equity and rollover $500m Sigura equity. After the acquisition, Platinum Equity will merge Solenis with its existing portfolio company Sigura Water. The US$290m downsize of the sr note tranches was shifted to the sr sec term loan B. Biz: Solenis produces specialty chemicals used in the manufacturing process for pulp and paper products and industrial water treatment. Sigura is a leading producer of pool chemicals for the residential market worldwide), as well as a provider of water care solutions to industrial, commercial, and municipal clients worldwide. HQ: Alpharetta, GA. (Acquisition announced 07/06/2021).
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.